Skip to main content

Table 3 Prevalence of MS and its components according to the quartiles of BMI/HDL-C, TG/HDL-C, WHTR and VAI

From: Developing a risk model for early diagnosis of metabolic syndrome in Chinese adults aged 40 years and above based on BMI/HDL-C: a cross-sectional study

 

Q1

Q2

Q3

Q4

χ2

P-value

Cramer’s V

Q1

Q2

Q3

Q4

χ2

P-value

Cramer’s V

 

BMI/HDL-C

TG/HDL-C

MS

36

(20.7)

62

(35.6) a

101

(58.0) a, b

130

(74.7) a, b,c

119.5

< 0.001

0.414

41

(23.6)

67

(38.7)a

97

(55.4)a, b

124

(71.3)a, b,c

89.2

< 0.001

0.358

Abdominal obesity

58

(33.3)

66

(37.9)

95

(54.6) a, b

117

(67.2) a, b

50.9

< 0.001

0.270

85

(48.9)

90

(52.0)

85

(49.1)

75

(43.1)

2.9

0.406

0.065

Hyperglycemia

107

(61.5)

119

(68.4)

133

(76.4) a

132

(75.9) a

12.5

< 0.001

0.134

121

(69.5)

125

(72.3)

125

(71.4)

120

(69.0)

0.6

0.896

0.029

Hypertension

79

(45.4)

89

(51.1)

104

(59.8) a

115

(66.1) a, b

17.7

< 0.001

0.160

82

(47.1)

103

(59.5)

99

(56.6)

103

(59.2)

7.1

0.068

0.101

Hypertriglyceridemia

39

(22.4)

71

(40.8) a

85

(48.9) a

111

(63.8) a, b,c

63.0

< 0.001

0.301

0

(0.0)

26

(15.0)a

107

(61.1)a, b

173

(99.4)a, b,c

433.5

< 0.001

0.789

HHDL

0

(0.0)

2

(1.1)

31

(17.8) a, b

109

(62.6) a, b,c

276.2

< 0.001

0.630

2

(1.1)

17

(9.8)a

37

(21.1)a, b

86

(49.4)a, b,c

141.9

< 0.001

0.452

 

WHTR

VAI

MS

53

(30.3)

55

(31.6)

103

(58.9)a, b

118

(67.4)a, b

75.4

< 0.001

0.328

41

(23.6)

56

(32.2)

111

(63.8)a, b

121

(69.5)a, b

108.8

< 0.001

0.395

Abdominal obesity

1

(0.6)

30

(17.2)a

131

(74.9)a, b

174

(99.4)a, b,c

459.6

< 0.001

0.811

76

(43.7)

80

(46.0)

98

(56.3)

82

(47.1)

6.4

0.091

0.096

Hyperglycemia

129

(73.7)

109

(62.6)

121

(69.1)

132

(75.4)

8.169

0.043

0.108

123

(70.7)

119

(68.4)

132

(75.9)

117

(67.2)

3.7

0.307

0.073

Hypertension

95

(54.3)

85

(48.9)

102

(58.3)

105

(60.0)

5.2

0.159

0.086

87

(50.0)

94

(54.0)

108

(62.1)

98

(56.3)

5.4

0.146

0.088

Hypertriglyceridemia

75

(42.9)

76

(43.7)

81

(46.3)

74

(42.3)

0.7

0.883

0.031

2

(1.1)

38

(21.8)a

95

(54.6)a, b

171

(98.3)a, b,c

380.4

< 0.001

0.739

HHDL

36

(20.6)

35

(20.1)

31

(17.7)

40

(22.9)

1.4

0.703

0.045

3

(1.7)

14

(8.0)a

44

(25.3)a, b

81

(46.6)a, b,c

129.6

< 0.001

0.431

  1. Data were expressed as n (%). The chi-square test was used to compare the differences between the quartiles of various indicators (BMI/HDL-C, TG/HDL-C, WHTR, and VAI) and MS and its components. The Cramer’s V coefficient was used to evaluate the correlation strength. 0.1 < Cramer’s V < 0.3 indicates a weak intensity correlation; 0.3 ≤ Cramer’s V < 0.5 indicates a moderate intensity correlation; Cramer’s V ≥ 0.5 indicates a high intensity correlation. (a: P < 0.05 vs. Q1 of the same indicator, b: P < 0.05 vs. Q2 of the same indicator, c: P < 0.05 vs. Q3 of the same indicator.). BMI, Body Mass Index; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; WHTR: waist-to-height ratio. VAI: visceral adiposity index. Quartile of BMI/HDL-C: Q1: < 17.168; Q2: 17.168 ~ 20.560; Q3: 20.560 ~ 24.229; Q4: ≥ 24.229; Quartile of TG/HDL-C: Q1: < 0.781; Q2: 0.781 ~ 1.265; Q3: 1.265 ~ 1.934; Q4: ≥ 1.934; Quartile of WHTR: Q1: < 0.511; Q2: 0.511 ~ 0.547; Q3: 0.547 ~ 0.581; Q4: ≥ 0.581; Quartile of VAI: Q1: < 1.343; Q2: 1.343 ~ 2.099; Q3: 2.099 ~ 3.322; Q4: ≥ 3.322. P < 0.05 was considered significant